stroke and brain injury, Completed Research

Insulin Resistance Intervention after Stroke Trial (IRIS): A StrokeNet Study

August 17, 2023

< 1

Insulin Resistance Intervention after Stroke Trial (IRIS): A StrokeNet Study

The Insulin Resistance Intervention after Stroke Trial (IRIS) was a randomized, double-blind, placebo-controlled trial that is testing the hypothesis that reducing insulin resistance and its sequelae with thiazolidinedione therapy will prevent stroke and myocardial infarction among patients with a recent ischemic stroke or transient ischemic attack. Pioglitazone reduced the relative risk of the primarily outcome (fatal & non-fatal stroke and MI) by 24% (p=0.007) vs. placebo.

Project Type: Research

Year started: 2016

Diagnosis: Stroke

Use of Low Magnet Strength MRI to Evaluate Stroke A study to evaluate the natural history of a...

TOPS - Take Off Pounds After Stroke A study post ischemic stroke participants to determine if a...

Explore our Stroke & Brain Injury Poster and Manuscript Research Which Road to Recovery? Factors...

Insulin Resistance Intervention after Stroke Trial (IRIS): A StrokeNet Study

Insulin Resistance Intervention after Stroke Trial (IRIS): A StrokeNet Study

Related posts

Use of Low Magnet Strength MRI to Evaluate Stroke

TOPS - Take Off Pounds After Stroke

Stroke & Brain Injury Poster and Manuscript Research